Clinical Trial Update: Crux Biomedical Vena Cava Filter Study - United States [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Crux Biomedical's vena cava filter for preventing pulmonary embolism has completed in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Crux Biomedical Vena Cava Filter

Snippet

Sponsor: Crux Biomedical | Conditions: Pulmonary Embolism | Phase 3 | Status: COMPLETED